NCT06044038

Brief Summary

The study aims to investigate the feasibility and adherence of long-term, moderate-intensity different types of physical activity programs for individuals with schizophrenia. Secondary outcomes are related to the control of non-communicable disease risk factors and the improvement of exercise capacity, body composition and cognitive function.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable schizophrenia

Timeline
Completed

Started Dec 2017

Longer than P75 for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2017

Completed
5.8 years until next milestone

First Submitted

Initial submission to the registry

September 5, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

September 21, 2023

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

September 21, 2023

Status Verified

September 1, 2023

Enrollment Period

8.1 years

First QC Date

September 5, 2023

Last Update Submit

September 19, 2023

Conditions

Keywords

SchizophreniaPhysical activityMental disorder

Outcome Measures

Primary Outcomes (5)

  • Peak Oxygen Uptake (VO2peak)

    Measurement of cardiorespiratory fitness, reported as ml/kg/min and estimated through a moderate and perceptually regulated 1km treadmill walk test (1k-TWT) or through related short-forms (500m or 200m)

    First assessment at the date of enrolment (baseline) and subsequently every six months until the date of the end of follow-up (up to 2 years)

  • Body Mass Index (kg/m²)

    Derived from the measurement of weight in kilograms and height in meters

    First assessment at the date of enrolment (baseline) and subsequently every six months until the date of the end of follow-up (up to 2 years)

  • Waist circumference (cm)

    Measurement of waist circumference

    First assessment at the date of enrolment (baseline) and subsequently every six months until the date of the end of follow-up (up to 2 years)

  • Screen for Cognitive Impairment in Psychiatry (SCIP)

    Values range from 0 to \>100, higher scores mean a better outcome

    First assessment at the date of enrolment (baseline) and subsequently every six months until the date of the end of follow-up (up to 2 years)

  • Frontal Assessment Battery (FAB)

    Values range from 0 to18, higher scores mean a better outcome

    First assessment at the date of enrolment (baseline) and subsequently every six months until the date of the end of follow-up (up to 2 years)

Secondary Outcomes (1)

  • Adherence

    From date of enrollment until the date of the end of follow-up (up to 2 years)

Study Arms (2)

Physical activity group

EXPERIMENTAL

Participation in supervised activities such as walking or Nordic walking groups, gentle gymnastics, soccer, swimming, and volleyball. Each activity was scheduled twice a week.

Behavioral: Physical activityBehavioral: Cognitive rehabilitation program

Usual care group

OTHER

Participants in the control group attended weekly 90-minute cognitive rehabilitation sessions according to the usual care procedure in this type of population.

Behavioral: Cognitive rehabilitation program

Interventions

Bi-weekly supervised physical activity intervention

Physical activity group

weekly 90-minute session consisting of welcoming participants, reviewing tasks conducted in the last meeting, and assignment of new pen-and-pencil cognitive and metacognitive tasks.

Physical activity groupUsual care group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with schizophrenia for at least 1 year
  • On antipsychotic medications with the same therapeutic regimen for at least 3 months before enrolment
  • Free of symptomatic peripheral arterial occlusive disease and cardiovascular, pulmonary, neurological, metabolic, and orthopaedic disorders that could interfere with physical activity sessions

You may not qualify if:

  • Recent modification of the therapeutic regimen
  • Presence of symptomatic peripheral arterial occlusive disease and cardiovascular, pulmonary, neurological, metabolic, and orthopaedic disorders that could interfere with physical activity sessions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Exercise Science and Sport

Ferrara, 44123, Italy

RECRUITING

Related Publications (1)

  • Mandini S, Morelli M, Belvederi Murri M, Grassi L, Masotti S, Simani L, Zerbini V, Raisi A, Piva T, Grazzi G, Mazzoni G. Adherence to a guided walking program with amelioration of cognitive functions in subjects with schizophrenia even during COVID-19 pandemic. BMC Sports Sci Med Rehabil. 2022 Mar 25;14(1):48. doi: 10.1186/s13102-022-00440-2.

MeSH Terms

Conditions

SchizophreniaMotor ActivityMental Disorders

Interventions

Exercise

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Gianni Mazzoni, Professor

    Università degli Studi di Ferrara

    STUDY DIRECTOR
  • Simona Mandini, PhD

    Università degli Studi di Ferrara

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Simona Mandini, PhD

CONTACT

Gianni Mazzoni, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 5, 2023

First Posted

September 21, 2023

Study Start

December 1, 2017

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

September 21, 2023

Record last verified: 2023-09

Locations